Evidence map›Paper›PMID 33622686›Full record

ArticleBMJ open diabetes research & care2021

Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR).

Hilde Kristin Refvik Riise, Jannicke Igland, Gerhard Sulo, Marit Graue, Johannes Haltbakk, Grethe Seppola Tell, Marjolein Memelink Iversen

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hilde Kristin Refvik RiiseDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Vestlandet, Norway hkrr@hvl.no.ORCID 0000-0003-4688-7447
Jannicke IglandDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Vestlandet, Norway.
Gerhard SuloCentre for Disease Burden, Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Vestlandet, Norway.
Marit GraueDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Vestlandet, Norway.
Johannes HaltbakkDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Vestlandet, Norway.
Grethe Seppola TellDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Vestlandet, Norway.
Marjolein Memelink IversenDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Vestlandet, Norway.
Western Norway University of Applied Sciences · NONorwegian Institute of Public Health · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOur aim was to assess the association between casual blood glucose level and subsequent cardiovascular disease (CVD) and mortality among community-dwelling adults without a diagnosis of diabetes. RESEARCH DESIGN AND

methodsIn this community-based cohort study, 159 731 individuals with a measurement of casual blood glucose were followed from their participation date in Cohort of Norway (CONOR) (1994-2003) until a CVD episode, death or 31 December 2009. All analyses were done using Cox proportional hazard regression, and the results are reported as multivariable-adjusted HRs with 95% CI.

resultsCompared with those with normal glucose levels (<7.8 mmol/L), participants categorized as having borderline (7.8-11.0 mmol/L) levels showed an increased risk of a stroke (HR 1.29; 95% CI 1.12 to 2.49) and cardiovascular (HR 1.29; 95% CI 1.12 to 2.48), and all-cause (HR 1.27; 95% CI 1.16 to 1.38) mortality, while participants with high glucose levels (>11.0 mmol/L) had an even more increased risk. One mmol/L increase in glucose level was associated with an increased risk of all four endpoints among participants with borderline as well as within normal glucose levels. In analyses stratified by sex and age group, the CVD risk estimates tended to be higher in women than in men and in those <65 years of age but no significant interactions were found.

conclusionAn increase in casual blood glucose levels, even within the range of normal and borderline levels, was positively associated with increased risk of CVD and mortality among community-dwelling adults without a known diagnosis of diabetes.

Indexed as

Cardiovascular DiseasesDiabetes MellitusAdultAgedBlood GlucoseCohort StudiesFemaleHumansMaleNorwayBlood Glucosecardiovascular systemglucoserisk factors

Identifiers

PMID33622686
PMCPMC7907851
OpenAlexW3129433473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.